Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

Clinical trial NCT02962661 · SUSPENDED

Trial details

NCT number: NCT02962661
Sponsor: M.D. Anderson Cancer Center
Status: SUSPENDED
Phase: Phase 1
Study type: INTERVENTIONAL

Cardiomyopathy Heart Failure Hematopoietic and Lymphoid Cell Neoplasm Malignant Solid Neoplasm

Start date: 2020-07-18
Primary completion: 2026-07-30
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.